[Influence of the different bisphosphonates dose regimens on its tolerability].
Osteoporosis is the most prevalent metabolic bone disease and fractures are its clinical complication. We have nowadays some drugs that reduce the incidence of new fractures: Bisphosphonates. Nevertheless, treatment must be taken properly in the long run to reduce the incidence of new fractures and a few months alter starting the treatment, a great number of patients stop it because of different reasons. The introduction of new bisphosphonates that can be taken weekly or even better monthly, has improved notably the adherence and compliance to osteoporosis treatment.
Sosa Henríquez
M
M
Universidad de Las Palmas de Gran Canaria, Facultad de Ciencias de la Salud, Grupo de Trabajo en Osteoporosis y Metabolismo Mineral, Hospital Universitario Insular, Las Palmas de Gran Canaria. manuelsosah@canariastelecom.com
Gómez de Tejada Romero
M J
MJ
D000368:Aged; D000369:Aged, 80 and over; D004164:Diphosphonates / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control*; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D010349:Patient Compliance
D004164:Diphosphonates